“Our long-term analysis of tirzepatide establishes that clinically relevant weight loss can be sustained for ... their initial weight depending on the dose [1]. This new analysis focuses on ...

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three ... initial weight depending on the dose . The researchers examined the ...

The winner of the first major head-to-head study of weight loss jabs has been revealed.

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

Share on Pinterest Mounjaro helps maintain weight loss at 3-year landmark, study confirms. Image credit: NurPhoto/Getty Images. According to a new study, a once-weekly dose of tirzepatide can lead ...

Participants were randomly assigned either to escalation of dulaglutide to 4.5 mg or maximum tolerated dose (MTD), or to ...

Nimacimab alone demonstrated 23.5% weight loss, comparable to monlunabant and tirzepatide alone ... CB1 knock-in mice that showed significant dose-dependent weight loss. Biomarker analyses ...